Deferoxamine mesylate improves splicing and GAA activity of the common c.-32-13T>G allele in late-onset Pompe disease patient fibroblasts

ABSTRACT: human Pompe Disease (c.-32-13T>G) fibroblasts were exposed to 10 µM Deferoxamine (DFX) or 0.1% DMSO (control condition), for three days.

ORGANISM(S): Homo sapiens

PROVIDER: GSE155637 | GEO | 2021/01/19

REPOSITORIES: GEO